Archives
Press Releases
advertisement
June 9, 2021
- Tandem Diabetes Care touts study results for insulin pump with closed-loop technology
- Dexcom shares clinical data on G7 CGM ahead of next-gen showdown with Abbott
- Sernova’s Principal Investigator Presents Positive New Data from Ongoing Type 1 Diabetes (T1D) Clinical Trial at ATC 2021 Virtual Connect Conference
- Humacyte Presents In Vivo Data on Biovascular Pancreas Transplantation for Type 1 Diabetes Treatment
- Blood sugar highs and lows linked to greater dementia risk in type 1 diabetes
- Measuring gene expression changes over time may help predict T1D diabetes progression
May 26, 2021
- Ascensia Diabetes Care launches new cloud-based diabetes management and analytics platform
- Roche’s new mySugar feature lets users control their insulin pump virtually
- RAMQ Now Offers Provincial Coverage of The Dexcom G6 Continuous Glucose Monitoring System for People Living with Type 1 Diabetes in Quebec
- Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
April 21, 2021
March 31, 2021
- The American Diabetes Association Praises Introduction of Affordable Insulin for the COVID-19 Emergency Act and the Minority Diabetes Initiative Act
- American Diabetes Association Urges Federal Action to Lower Prescription Drug Prices
- Team Novo Nordisk Announce 2021 Development Team Roster
- Yale New Haven Health Undertakes Real-world Evaluation of DreaMed Diabetes’s Advisor Pro Through Virtual Clinic
- MannKind to Participate in 2022 Medicare Part D Senior Savings Model to Make Insulin More Affordable for Seniors
March 24, 2021
- Insulet’s Omnipod® 5 Automated Insulin Delivery System Improves Clinical Outcomes in Type 1 Diabetes (See also: Tubeless automated insulin delivery system improves blood glucose outcomes)
- Zealand Pharma Announces FDA Approval of Zegalogue® (dasiglucagon) injection, for the Treatment of Severe Hypoglycemia in People with Diabetes
advertisement
